Trials / Completed
CompletedNCT02103452
Edessy Stem Cell Score (ESS), Endometrium, Endometrioma
Edessy STEM CELL SCORE (ESS), Endometrium, Endometrioma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Purpose of this study is to evaluate stem cell expression (SCE) in endometriotic (E) and non endometriotic ovarian and endometrial tissues.
Detailed description
This study was conducted on 40 women at Al-Azhar University Hospitals. They are divided into two equal groups, group 1 with ovarian endometrioma and group 2 with normal ovary. Ovarian and endometrial samples were evaluated by hematoxlin \& eosin for histopathology (HP) and of oct-4 for immunohistochemistry (IH) for SCE. Evaluation of IH parameters revealed that the most important factors for evaluating SC were arranged as score ( Edessy Stem Cell Score=ESS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Ovarian and endometrial samples | Ovarian and endometrial samples were evaluated by hematoxlin \&eosin for histopathology (HP) and of oct-4 for immunohistochemistry (IH) for SCE |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2014-04-04
- Last updated
- 2014-04-04
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02103452. Inclusion in this directory is not an endorsement.